Low-Dose Ticagrelor in Patients With High Ischemic Risk and Previous Myocardial Infarction: A Multicenter Prospective Real-World Observational Study
In conclusion, in a real-world study, including patients with previous MI, low-dose ticagrelor for prolonged dual antiplatelet therapy showed to be effective and safe, with no major bleeding occurring at follow-up.
Source: Journal of Cardiovascular Pharmacology - Category: Cardiology Tags: Original Article Source Type: research
More News: Aspirin | Bleeding | Cardiology | Cardiovascular | Chronic Kidney Disease | Drugs & Pharmacology | Heart | Heart Attack | Ischemic Stroke | Italy Health | Stroke | Study | Urology & Nephrology